ARCHIVES

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

This article is from The Cancer Letter archive.

Vol. 18 No. 35 | September 11, 1992

Download PDF Visit The Full Archive

Related Articles

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

In Brief: Two Major Appointments Made At Fox Chase; HHS Names Task Force to Look At DRG Research Impact

April 20, 1984

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006